Heron Therapeutics, Inc.

Heron Therapeutics, Inc.verified

HRTX

Price:

$1.58

Market Cap:

$240.31M

Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor...[Read more]

Industry

Biotechnology

IPO Date

1987-08-26

Stock Exchange

NASDAQ

Ticker

HRTX

The Enterprise Value as of December 2024 (TTM) for Heron Therapeutics, Inc. (HRTX) is 392.82M

According to Heron Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 392.82M. This represents a change of -25.90% compared to the average of 530.09M of the last 4 quarters.

Heron Therapeutics, Inc. (HRTX) Historical Enterprise Value (quarterly & annually)

How has HRTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Heron Therapeutics, Inc. over the last ten years is 975.49M. The current 392.82M Enterprise Value has changed 3.93% with respect to the historical average. Over the past ten years (40 quarters), HRTX's Enterprise Value was at its highest in in the June 2018 quarter at 2.57B. The Enterprise Value was at its lowest in in the December 2014 quarter at 222.78M.

Quarterly (TTM)
Annual

Average

975.49M

Median

836.26M

Minimum

196.21M

Maximum

1.87B

Heron Therapeutics, Inc. (HRTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Heron Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 312.98%

Maximum Annual Enterprise Value = 1.87B

Minimum Annual Increase = -57.20%

Minimum Annual Enterprise Value = 196.21M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023385.78M-6.88%
2022414.30M-57.20%
2021967.99M-47.41%
20201.84B-1.55%
20191.87B-0.09%
20181.87B117.04%
2017862.23M60.77%
2016536.31M-33.81%
2015810.30M312.98%
2014196.21M164.41%

Heron Therapeutics, Inc. (HRTX) Average Enterprise Value

How has HRTX Enterprise Value performed in the past?

The current Enterprise Value of Heron Therapeutics, Inc. (HRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

589.36M

5-year avg

1.10B

10-year avg

975.49M

Heron Therapeutics, Inc. (HRTX) Enterprise Value vs. Peers

How is HRTX’s Enterprise Value compared to its peers?

Heron Therapeutics, Inc.’s Enterprise Value is less than Mereo BioPharma Group plc (510.15M), greater than Terns Pharmaceuticals, Inc. (223.81M), greater than PDS Biotechnology Corporation (36.27M), greater than Inozyme Pharma, Inc. (210.44M), greater than HOOKIPA Pharma Inc. (-38628737.00), greater than X4 Pharmaceuticals, Inc. (79.71M), greater than Acumen Pharmaceuticals, Inc. (104.35M), less than Day One Biopharmaceuticals, Inc. (857.57M), greater than Eledon Pharmaceuticals, Inc. (248.84M),

Build a custom stock screener for Heron Therapeutics, Inc. (HRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Heron Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Heron Therapeutics, Inc. (HRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Heron Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Heron Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Heron Therapeutics, Inc. (HRTX)?

What is the 3-year average Enterprise Value for Heron Therapeutics, Inc. (HRTX)?

What is the 5-year average Enterprise Value for Heron Therapeutics, Inc. (HRTX)?

How does the current Enterprise Value for Heron Therapeutics, Inc. (HRTX) compare to its historical average?